Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
LSE:0H9X
RESEARCH TOOLSreports
0H9X Stock Chart & Stats
Day’s Range― - ―
52-Week Range€32.50 - €48.28
Previous CloseN/A
Volume32.07K
Average Volume (3M)161.47K
Market Cap
€13.46B
Enterprise Value€23.80B
Total Cash (Recent Filing)€1.15B
Total Debt (Recent Filing)€12.03B
Price to Earnings (P/E)25.1
Beta1.26
Next Earnings
May 06, 2025EPS Estimate
0.81Next Dividend Ex-Date
May 23, 2025Dividend Yield2.58%
Share Statistics
EPS (TTM)1.83
Shares Outstanding293,413,450
10 Day Avg. Volume170,222
30 Day Avg. Volume161,467
Financial Highlights & Ratios
PEG Ratio3.22
Price to Book (P/B)N/A
Price to Sales (P/S)0.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€46.00Price Target Upside-0.13% Downside
Rating ConsensusHold
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFresenius Medical Care beat expectations on sales and EBIT, driven by positive price and volume in Care Enablement and stable US treatment volumes.
Market PositionThe company is the only one with FDA-approved technology for high-volume hemodiafiltration, positioning it advantageously in the market.
Operational EfficiencyThe introduction of new technology, such as the 5008X machine, is expected to support clinic utilization and improve patient care, enhancing operational efficiency.
Bears Say
Market ChallengesThere is continued caution on the dialysis market, which is seen as structurally challenged and at risk of reimbursement changes.
Regulatory ImpactPremium subsidies for ACA exchanges are likely to end, which could negatively impact the coverage for some patients and slightly affect EBIT.
Valuation ConcernsAt the current valuation, Fresenius Medical Care remains a Sell.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
18.60%
Mutual Funds
<0.01% Other Institutional Investors
74.41% Public Companies and
Individual Investors
0H9X FAQ
What was Fresenius Medical Care AG & Co. KGaA’s price range in the past 12 months?
Fresenius Medical Care AG & Co. KGaA lowest share price was €32.50 and its highest was €48.28 in the past 12 months.
What is Fresenius Medical Care AG & Co. KGaA’s market cap?
Fresenius Medical Care AG & Co. KGaA’s market cap is €13.46B.
When is Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date?
Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date is May 06, 2025 which is in 31 days.
How were Fresenius Medical Care AG & Co. KGaA’s earnings last quarter?
Fresenius Medical Care AG & Co. KGaA released its earnings results on Feb 25, 2025. The company reported €0.91 earnings per share for the quarter, beating the consensus estimate of €0.799 by €0.111.
Is Fresenius Medical Care AG & Co. KGaA overvalued?
According to Wall Street analysts Fresenius Medical Care AG & Co. KGaA’s price is currently Overvalued.
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Fresenius Medical Care AG & Co. KGaA pays a Annually dividend of €1.19 which represents an annual dividend yield of 2.58%. See more information on Fresenius Medical Care AG & Co. KGaA dividends here
What is Fresenius Medical Care AG & Co. KGaA’s EPS estimate?
Fresenius Medical Care AG & Co. KGaA’s EPS estimate is 0.81.
How many shares outstanding does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding.
What happened to Fresenius Medical Care AG & Co. KGaA’s price movement after its last earnings report?
Fresenius Medical Care AG & Co. KGaA reported an EPS of €0.91 in its last earnings report, beating expectations of €0.799. Following the earnings report the stock price went up 1.263%.
Which hedge fund is a major shareholder of Fresenius Medical Care AG & Co. KGaA?
Currently, no hedge funds are holding shares in GB:0H9X
---
Fresenius Medical Care AG & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€46.00 (-0.13% Downside)
€46.00 (-0.13% Downside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.11%
12-Months-Change
Fundamentals
Return on Equity
3.82%
Trailing 12-Months
Asset Growth
-1.07%
Trailing 12-Months
Company Description
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
---
0H9X Stock 12 Month Forecast
Average Price Target
€46.00
▼(-0.13% Downside)
Technical Analysis
Best Analysts Covering 0H9X
1 Year
1 Year Success Rate
14/20 ratings generated profit
1 Year Average Return
+11.43%
reiterated a buy rating 2 months ago
Copying Victoria Lambert's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +11.43% per trade.
---